SIFI sigla una joint venture con AffaMed Therapeutics per servire il mercato cinese

Paolo Bossi
Tagged:

Lo studio legale DLA Piper ha assistito la società farmaceutica SIFI S.p.A. nella joint venture strategica con la biofarmaceutica cinese AffaMed Therapeutics finalizzata a sviluppare, produrre…

This content is for members only.
Join Now
Already a member? Accedi

Author: Paolo Bossi

Co-Founder of More Legal Srl, Journalist and Chief Editor of Global Legal Chronicle’s magazines…

This content is for members only.
Join Now
Already a member? Accedi